Placement near the intended tissue allows the medication to diffuse into nearby cells, where it can interact with receptors or enzymes. This can raise drug concentration at the site requiring treatment without requiring equivalent distribution throughout the body. The resulting effect depends on how effectively the drug moves through the local tissue and reaches its pharmacological target.
Tissue barriers can restrict movement from the application site into nearby cells, while local clearance can remove the medication before sufficient exposure occurs. These processes may reduce the concentration available for receptor or enzyme interactions. Consequently, a drug placed near its target may still produce a weak effect if penetration or persistence within that tissue is limited.
The main distinction is where drug exposure is concentrated. Local delivery aims to produce a stronger effect in the treated tissue, whereas primarily systemic distribution exposes a broader range of tissues. Local exposure may reduce contact with distant tissues, but this benefit is not assured because diffusion, tissue barriers, clearance, and placement accuracy influence how far the medication spreads.
The appropriate route depends on the anatomical site and the formulation used. Topical delivery can address skin, inhaled delivery can reach the airways, and ophthalmic delivery targets the eye. Intralesional and intra-articular approaches place medication within a lesion or joint, respectively. Matching the delivery approach to the target site supports more focused pharmacological action.
Planning should account for the target tissue, the route of placement, and the formulation selected for that anatomical site. Researchers or clinicians must also consider whether tissue barriers could restrict diffusion, whether local clearance could shorten exposure, and whether placement is accurate. These factors determine whether enough medication reaches nearby cells to interact with its target.
Local delivery is relevant when the desired effect concerns a defined tissue or organ, including skin disorders, airway disease, eye conditions, and joint inflammation. It allows pharmacology studies to examine how drug concentration near a target relates to receptor or enzyme interactions. The approach also helps evaluate whether limiting distant tissue exposure can support a more focused treatment effect.